Macular Hemorrhage Due to Age-Related Macular Degeneration or Retinal Arterial Macroaneurysm: Predictive Factors of Surgical Outcome.
age-related macular degeneration
macular hematoma
macular hemorrhage
prognosis
retinal arterial macroaneurysm
treat and extend
vitrectomy
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
10 Dec 2021
10 Dec 2021
Historique:
received:
04
11
2021
revised:
30
11
2021
accepted:
07
12
2021
entrez:
24
12
2021
pubmed:
25
12
2021
medline:
25
12
2021
Statut:
epublish
Résumé
The study aimed to determine the outcomes and prognostic factors of vitrectomy, subretinal injection of tissue-plasminogen activator and gas tamponade in macular hemorrhage (MaH) due to age-related macular degeneration (AMD) or retinal arterial macroaneurysm (RAM). The study design utilized a multicentric retrospective case series design of consecutive patients undergoing surgery between 2014 and 2019. A total of 65 eyes from 65 patients were included in the study. Surgery was performed after a mean period of 7.1 days. Displacement of MaH was achieved in 82% of the eyes. Mean best-corrected visual acuity (BCVA) improved from 20/500 to 20/125 at month(M)1 and M6 ( MaH surgery stabilizes or improves BCVA in 85% of cases. Younger age at diagnosis, better baseline BCVA figures, smaller subretinal MaH height and use of TE regime were predictive of the best postoperative outcomes.
Identifiants
pubmed: 34945083
pii: jcm10245787
doi: 10.3390/jcm10245787
pmc: PMC8703651
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Jpn J Ophthalmol. 2012 Nov;56(6):589-98
pubmed: 23053632
Retina. 2019 Jan;39(1):172-179
pubmed: 29135798
Retina. 2015 Oct;35(10):1969-78
pubmed: 26079475
Am J Ophthalmol. 2014 Jun;157(6):1250-7
pubmed: 24531021
Medwave. 2020 Mar 3;20(2):e7831
pubmed: 32225130
Retina. 2013 Sep;33(8):1551-7
pubmed: 23652578
Am J Ophthalmol. 2001 Feb;131(2):208-15
pubmed: 11228297
Clin Ophthalmol. 2010 Jul 21;4:637-42
pubmed: 20668667
Arch Ophthalmol. 1991 May;109(5):723-9
pubmed: 2025175
Surv Ophthalmol. 2016 Jan-Feb;61(1):18-32
pubmed: 26212151
Graefes Arch Clin Exp Ophthalmol. 1999 Apr;237(4):273-7
pubmed: 10208258
Ophthalmologica. 1999;213(2):97-102
pubmed: 9885385
Retina. 2016 Oct;36(10):1860-5
pubmed: 26945238
Ophthalmology. 2004 Jun;111(6):1201-8
pubmed: 15177972
Br J Ophthalmol. 2010 Jan;94(1):48-53
pubmed: 19946027
Arch Ophthalmol. 1987 Dec;105(12):1722-3
pubmed: 3689195
Arch Ophthalmol. 1990 Jul;108(7):973-8
pubmed: 2369357
Retina. 2016 May;36(5):914-25
pubmed: 26807631
Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1115-1123
pubmed: 28280989
J Fr Ophtalmol. 2019 Nov;42(9):e391-e397
pubmed: 31471124
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4071-7
pubmed: 18421081
Retina. 2010 Feb;30(2):203-11
pubmed: 19952998
Br J Ophthalmol. 2012 May;96(5):708-13
pubmed: 22174095
Semin Ophthalmol. 2011 Nov;26(6):361-71
pubmed: 22044334
Eye (Lond). 2016 Jul;30(7):929-35
pubmed: 27055681
Retina. 2014 Jun;34(6):1156-62
pubmed: 24296398